Penumbra

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Penumbra and other ETFs, options, and stocks.

About PEN

Penumbra, Inc. is a thrombectomy company, which designs, develops, manufactures, and markets innovative medical products. It offers neurovascular thrombectomy and embolization and access technologies, neurosurgical tools, Penumbra LANTERN Delivery Microcatheter, and Penumbra Occlusion Device system. 

CEO
Adam Elsesser
CEOAdam Elsesser
Employees
4,500
Employees4,500
Headquarters
Alameda, California
HeadquartersAlameda, California
Founded
2004
Founded2004
Employees
4,500
Employees4,500

PEN Key Statistics

Market cap
10.72B
Market cap10.72B
Price-Earnings ratio
777.33
Price-Earnings ratio777.33
Dividend yield
Dividend yield
Average volume
459.56K
Average volume459.56K
High today
$280.77
High today$280.77
Low today
$273.03
Low today$273.03
Open price
$275.21
Open price$275.21
Volume
320.09K
Volume320.09K
52 Week high
$310.00
52 Week high$310.00
52 Week low
$148.00
52 Week low$148.00

PEN News

Simply Wall St 4d
Investors more bullish on Penumbra this week as stock lifts 6.4%, despite earnings trending downwards over past five years

If you buy and hold a stock for many years, you'd hope to be making a profit. But more than that, you probably want to see it rise more than the market average....

Investors more bullish on Penumbra this week as stock lifts 6.4%, despite earnings trending downwards over past five years
TipRanks 4d
Cautious Outlook on Penumbra’s Thunderbolt Amid Trial Uncertainty and Market Delay

Penumbra (PEN – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Kallum Titchmarsh from Morgan Stanley...

Analyst ratings

71%

of 21 ratings
Buy
71.4%
Hold
23.8%
Sell
4.8%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.